Topotecan can be administered either intravenously or orally. The intravenous form is typically given over a few days in a cycle, whereas the oral form allows for more flexible dosing schedules. The specific regimen depends on the type and stage of the cancer being treated, as well as the patient's overall health and response to the medication.
